FDA clears Varian's new Helios IMRT (intensity modulated radiation therapy) software:
This article was originally published in Clinica
Executive Summary
Varian Medical Systems has received US FDA 510(k) clearance to market a rapid new version of its inverse treatment planning software for its SmartBeam intensity modulated radiation therapy system (IMRT). The Helios 6.5 software runs on the company's Eclipse platform, which was introduced last year to expedite and improve the quality of radiation treatment planning in a Windows environment. "This new software brings all of the power, speed and industry-leading features of our Eclipse platform to the inverse treatment planning process for IMRT," said Tim Guertin, president of the Palo Alto, California firm's oncology business.